The monoclonal antibody treatment therapy that was used in former US President Donald Trump’s COVID treatment and known as Trump Cocktail Therapy is now available at two private hospitals in the city. This therapy was recently approved by the Central Drugs Standard Control Organization (CDSCO) of India.
Dr Rakesh Kapoor, Director, Medanta Hospital said, ‘A 55-year-old male COVID patient has become the first person to receive ‘cocktail therapy’ in Lucknow on Sunday. He was given medicine by Dr. Ruchita Sharma. The patient has experienced a decrease in symptoms and viral load. At present, the cost of treatment is Rs 60,000.
Facility will also be available in Apollomedics Hospital
Dr. Mayank Somani, Managing Director, Apolomedics Super Specialty Hospital, said, ‘Monoclonal antibody cocktail therapy, also known as’ trump cocktail’, is now available in our hospital. The method of treatment is effective in mild or moderate COVID patients where oxygen support is not required. The therapy should be given within 10 days of a patient testing positive for the infection.’
effective in reducing damage
Experts said the cocktail therapy was administered through a drug, Regeneron, which is a combination of two synthetic antibodies, castrivimab and imdevimab, developed in laboratories. It has been found that the cocktail of antibodies blocks the entry of the novel coronavirus into a human cell, thus preventing it from replicating and damaging the cell before it can travel to other cells in the body.
The patient is kept under observation for an hour
The drug is administered into the patient’s body through the intra-vein method which takes about an hour. If there are no complications, the patient is kept under observation for an hour before being sent home. The therapy is usually given to patients with comorbidities who are more likely to have severe COVID infection.
Disclaimer: This post has been auto-published from an agency/news feed without any modifications to the text and has not been reviewed by an editor.